Solesta®

GUDID 00365649850035

SOLESTA® is indicated for the treatment of fecal incontinence in patients 18 years and older who have failed conservative therapy (eg. diet, fiber therapy, anti-motility medications).

SALIX PHARMACEUTICALS, LTD.

Anal tissue reconstructive material
Primary Device ID00365649850035
NIH Device Record Keydeb3c664-29a9-4a16-8813-38ea2ffe3bbb
Commercial Distribution StatusIn Commercial Distribution
Brand NameSolesta®
Version Model Number1085003
Company DUNS793108036
Company NameSALIX PHARMACEUTICALS, LTD.
Device Count1
DM Exemptfalse
Pre-market Exemptfalse
MRI Safety StatusLabeling does not contain MRI Safety Information
Human Cell/Tissue Productfalse
Device Kitfalse
Device Combination Productfalse
Single Usetrue
Lot Batchtrue
Serial Numberfalse
Manufacturing Datefalse
Expiration Datetrue
Donation Id Numberfalse
Contains Natural Rubber Latexfalse
Labeled No Natural Rubber Latexfalse
RX Perscriptiontrue
OTC Over-The-Counterfalse

Customer Support Contacts

Phone8005080024
Emailsalix@medcomsol.com
Phone8005080024
Emailsalix@medcomsol.com
Phone8005080024
Emailsalix@medcomsol.com
Phone8005080024
Emailsalix@medcomsol.com
Phone8005080024
Emailsalix@medcomsol.com
Phone8005080024
Emailsalix@medcomsol.com
Phone8005080024
Emailsalix@medcomsol.com
Phone8005080024
Emailsalix@medcomsol.com
Phone8005080024
Emailsalix@medcomsol.com
Phone8005080024
Emailsalix@medcomsol.com
Phone8005080024
Emailsalix@medcomsol.com
Phone8005080024
Emailsalix@medcomsol.com
Phone8005080024
Emailsalix@medcomsol.com
Phone8005080024
Emailsalix@medcomsol.com

Device Identifiers

Device Issuing AgencyDevice ID
GS100365649850035 [Primary]
GS110365649850032 [Package]
Package: Transport box [32 Units]
In Commercial Distribution

FDA Pre-market Approvals/Notifications & deNovo

FDA Product Code

LNMAgent, Bulking, Injectable For Gastro-Urology Use

Sterilization

Steralize Prior To Usefalse
Device Is Steriletrue

Device Entry Metadata

Public Version StatusUpdate
Device Record StatusPublished
Public Version Number3
Public Version Date2018-07-06
Device Publish Date2014-10-31

Devices Manufactured by SALIX PHARMACEUTICALS, LTD.

00365649850035 - Solesta®2018-07-06SOLESTA® is indicated for the treatment of fecal incontinence in patients 18 years and older who have failed conservative therapy (eg. diet, fiber therapy, anti-motility medications).
00365649850035 - Solesta®2018-07-06 SOLESTA® is indicated for the treatment of fecal incontinence in patients 18 years and older who have failed conservative thera
00365649922039 - Deflux®2018-07-06 Deflux® is a bulking agent indicated for treatment of children with vesicoureteral reflux (VUR) grades II-IV.

Trademark Results [Solesta]

Mark Image

Registration | Serial
Company
Trademark
Application Date
SOLESTA
SOLESTA
90465463 not registered Live/Pending
Galderma Holding S.A.
2021-01-14
SOLESTA
SOLESTA
88090466 not registered Live/Pending
Néstlé Skin Health S.A.
2018-08-23
SOLESTA
SOLESTA
78853445 3352167 Dead/Cancelled
NESTLÉ SKIN HEALTH S.A.
2006-04-04

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.